Capital Advisors Ltd. LLC Purchases 43 Shares of Humana Inc. (NYSE:HUM)

Capital Advisors Ltd. LLC raised its position in Humana Inc. (NYSE:HUM) by 26.1% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 208 shares of the insurance provider’s stock after acquiring an additional 43 shares during the period. Capital Advisors Ltd. LLC’s holdings in Humana were worth $53,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently made changes to their positions in the company. Pinnacle Wealth Management Advisory Group LLC raised its stake in shares of Humana by 3.6% during the 4th quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider’s stock valued at $272,000 after purchasing an additional 37 shares during the period. Atlas Brown Inc. raised its stake in shares of Humana by 0.6% during the 4th quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider’s stock valued at $1,611,000 after purchasing an additional 38 shares during the period. Moors & Cabot Inc. raised its stake in shares of Humana by 2.5% during the 3rd quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider’s stock valued at $519,000 after purchasing an additional 40 shares during the period. Mather Group LLC. raised its stake in shares of Humana by 21.0% during the 4th quarter. Mather Group LLC. now owns 236 shares of the insurance provider’s stock valued at $60,000 after purchasing an additional 41 shares during the period. Finally, Your Advocates Ltd. LLP raised its stake in shares of Humana by 81.8% during the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after purchasing an additional 45 shares during the period. 92.38% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research firms recently issued reports on HUM. Morgan Stanley decreased their price objective on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 12th. Bank of America upgraded Humana from an “underperform” rating to a “neutral” rating and boosted their price objective for the company from $247.00 to $308.00 in a research note on Wednesday, November 6th. Royal Bank of Canada restated an “outperform” rating and set a $283.00 target price on shares of Humana in a research report on Wednesday, February 12th. Truist Financial boosted their target price on Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Finally, TD Cowen boosted their target price on Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Nineteen research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, Humana presently has an average rating of “Hold” and an average price target of $285.68.

Humana Price Performance

HUM opened at $255.02 on Tuesday. The stock has a 50-day moving average price of $269.30 and a 200-day moving average price of $288.93. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $30.77 billion, a P/E ratio of 25.63, a PEG ratio of 2.05 and a beta of 0.56.

Humana (NYSE:HUM) last issued its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Equities analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.39%. The ex-dividend date of this dividend is Friday, March 28th. Humana’s dividend payout ratio is presently 35.58%.

Insider Activity at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.32% of the stock is currently owned by company insiders.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.